SDT/Jcl |
blood glucose level |
specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) |
Fuse M, et al., Physiol Genomics. 2008 Jul 8;. |
blood glucose amount |
male |
420 days
| 5 |
767.2 |
mg/dl |
17.6 |
39.35 |
oral glucose tolerance test |
0 |
oral dose |
30 |
min |
|
13166 |
106 |
F344/NSlc |
blood glucose level |
specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) |
Fuse M, et al., Physiol Genomics. 2008 Jul 8;. |
blood glucose amount |
male |
420 days
| 7 |
134.1 |
mg/dl |
4.7 |
12.44 |
oral glucose tolerance test |
0 |
oral dose |
15 |
min |
|
13157 |
106 |
F344/NSlc |
blood glucose level |
specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) |
Fuse M, et al., Physiol Genomics. 2008 Jul 8;. |
blood glucose amount |
male |
420 days
| 7 |
149.0 |
mg/dl |
3.52 |
9.31 |
oral glucose tolerance test |
0 |
oral dose |
120 |
min |
|
13160 |
106 |
F344/NSlc |
blood glucose level |
specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) |
Fuse M, et al., Physiol Genomics. 2008 Jul 8;. |
blood glucose amount |
male |
420 days
| 7 |
99.0 |
mg/dl |
4.48 |
11.85 |
oral glucose tolerance test |
0 |
oral dose |
0 |
min |
|
13156 |
106 |
F344/NSlc |
blood glucose level |
specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) |
Fuse M, et al., Physiol Genomics. 2008 Jul 8;. |
blood glucose amount |
male |
420 days
| 7 |
157.0 |
mg/dl |
5.21 |
13.78 |
oral glucose tolerance test |
0 |
oral dose |
60 |
min |
|
13159 |
106 |
SDT/Jcl |
blood glucose level |
specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) |
Fuse M, et al., Physiol Genomics. 2008 Jul 8;. |
blood glucose amount |
male |
420 days
| 5 |
566.2 |
mg/dl |
26.69 |
59.68 |
oral glucose tolerance test |
0 |
oral dose |
0 |
min |
|
13162 |
106 |
SDT/Jcl |
blood glucose level |
specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) |
Fuse M, et al., Physiol Genomics. 2008 Jul 8;. |
blood glucose amount |
male |
420 days
| 5 |
640.6 |
mg/dl |
16.99 |
37.99 |
oral glucose tolerance test |
0 |
oral dose |
120 |
min |
|
13168 |
106 |
F344/NSlc |
blood glucose level |
specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) |
Fuse M, et al., Physiol Genomics. 2008 Jul 8;. |
blood glucose amount |
male |
420 days
| 7 |
149.1 |
mg/dl |
4.2 |
11.11 |
oral glucose tolerance test |
0 |
oral dose |
30 |
min |
|
13158 |
106 |
SDT/Jcl |
blood glucose level |
specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) |
Fuse M, et al., Physiol Genomics. 2008 Jul 8;. |
blood glucose amount |
male |
420 days
| 5 |
705.0 |
mg/dl |
46.77 |
104.58 |
oral glucose tolerance test |
0 |
oral dose |
15 |
min |
|
13164 |
106 |
F344/NSlc |
blood glucose level |
specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. |
blood glucose amount |
male |
211 days
| 7 |
78.0 |
mg/dl |
2.6 |
6.88 |
oral glucose tolerance test |
0 |
oral glucose |
0 |
min |
ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN) |
12770 |
311 |
F344.OLETF-(D7Rat18-D7Mit2)(D14Rat23-D14Rat12)/Tj |
blood glucose level |
specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. |
blood glucose amount |
male |
211 days
| 11 |
87.7 |
mg/dl |
3.2 |
10.61 |
oral glucose tolerance test |
0.0 |
oral glucose |
0 |
min |
ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN) |
12798 |
311 |
F344.OLETF-(D7Mgh16-D7Mgh20)/Tj |
blood glucose level |
specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. |
blood glucose amount |
male |
211 days
| 7 |
78.7 |
mg/dl |
3.4 |
9.0 |
oral glucose tolerance test |
0 |
oral glucose |
0 |
min |
ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN) |
12786 |
311 |
F344.OLETF-(D14Rat23-D14Rat12)/Tj |
blood glucose level |
specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. |
blood glucose amount |
male |
211 days
| 11 |
82.5 |
mg/dl |
3.5 |
11.61 |
oral glucose tolerance test |
0 |
oral glucose |
0 |
min |
ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN) |
12792 |
311 |
SDT/Jcl |
blood glucose level |
specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) |
Fuse M, et al., Physiol Genomics. 2008 Jul 8;. |
blood glucose amount |
male |
420 days
| 5 |
702.8 |
mg/dl |
25.39 |
56.77 |
oral glucose tolerance test |
0 |
oral dose |
60 |
min |
|
13167 |
106 |